zurück zur Startseite
Zentrale Tel.: 06221-560
SFB 938

Projekt C – Heeg

Ziegler, S., K. Gartner, U. Scheuermann, T. Zoeller, J. Hantzschmann, B. Over, S. Foermer, K. Heeg, and I. Bekeredjian-Ding. 2014. Ca(2+) -related signaling events influence TLR9-induced IL-10 secretion in human B cells. Eur. J. Immunol. 44(5):1285-98.
Ziegler, S., M. E. Eberle, S. J. Wölfle, K. Heeg, and I. Bekeredjian-Ding. 2013. Bifunctional Oligodeoxynucleotide/AntagomiR Constructs: Evaluation of a New Tool for MicroRNA Silencing. Nucleic Acid Therapeutics 23: 427–434.
Parcina, M., M. A. Miranda-Garcia, S. Durlanik, S. Ziegler, B. Over, P. Georg, S. Foermer, S. Ammann, D. Hilmi, K.-J. Weber, M. Schiller, K. Heeg, W. Schneider-Brachert, F. Götz, and I. Bekeredjian-Ding. 2013. Pathogen-Triggered Activation of Plasmacytoid Dendritic Cells Induces IL-10–Producing B Cells in Response to Staphylococcus aureus. J. Immunol. 190: 1591–1602.
Over, B., S. Ziegler, S. Foermer, A. N. R. Weber, K. A. Bode, K. Heeg, and I. Bekeredjian-Ding. 2013. IRAK4 turns IL-10+ phospho-FOXO+ monocytes into pro-inflammatory cells by suppression of protein kinase B. Eur. J. Immunol. 43: 1630–1642.
Doster, A., S. Ziegler, S. Foermer, R. J. Rieker, K. Heeg, and I. Bekeredjian-Ding. 2013. PTO-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for TLR9 in receptor revision. Immunology 139: 166–178.

Opens external link in new windowPoke Weed Mitogen Requires Toll-Like Receptor Ligands for Proliferative Activity in Human and Murine B Lymphocytes (PubMed)

Bekeredjian-Ding, I., S. Foermer, C. J. Kirschning, M. Parcina, and K. Heeg. 2012.

PLoS ONE 7: e29806.

Opens external link in new windowPD-L1 expression on tolerogenic APCs is controlled by STAT-3. (PubMed)

Wölfle, S. J., J. Strebovsky, H. Bartz, A. Sähr, C. Arnold, C. Kaiser, A. H. Dalpke, and K. Heeg. 2011.

Eur. J. Immunol. 41: 413–424.

Select languageSelect language
Print Diese Seite per E-Mail weiterempfehlen